Abstract
The importance of vitamin B6 is evident by its role as the most abundant cofactor in human metabolism. A total of six different B6 vitamers follow a complex pathway of absorption and transformation into the final active cofactor, pyridoxal 5′-phosphate (PLP), which catalyses over 100 reactions, mainly in amino acid and neurotransmitter metabolism. Over recent years a number of genetic defects have been identified as the underlying cause of vitamin B6-dependent epilepsies that need to be considered particularly in neonatal, therapy-resistant seizures of unclear aetiology. With diagnostic delay these disorders can be fatal or may lead to irreversible brain damage. Therefore, a standardised vitamin B6 trial should be part of a protocol for neonatal seizures in every institution caring for the critically ill newborn. The underlying mechanisms of vitamin B6-dependent epilepsies can be assigned to either reduced production/availability of PLP or to inactivation of PLP by accumulating compounds and formation of a Knoevenagel product. The disorders can be distinguished by specific biomarkers in urine, plasma or CSF and confirmed by molecular testing. Affected patients need a lifelong oral treatment with pyridoxine or pyridoxal 5′-phosphate and withdrawal will inevitably lead to recurrence of seizure. Due to autosomal recessive inheritance, recurrence risk for all disorders discussed here is 25 % and intrauterine treatment with vitamin B6 administered to the mother from early pregnancy may be considered in forthcoming pregnancies. Prenatal testing is available by molecular analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albersen M, Groenendaal F, van der Ham M, de Koning TJ, Bosma M, Visser WF, Visser G, de Sain-van der Velden MG, Verhoeven-Duif NM (2012) Vitamin B6 vitamer concentrations in cerebrospinal fluid differ between preterm and term newborn infants. Pediatrics 130(1):e191–e198
Balasubramaniam S, Bowling F, Carpenter K, Earl J, Chaitow J, Pitt J, Mornet E, Sillence D, Ellaway C (2010) Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5′-phosphate availability. J Inherit Metab Dis 33(Suppl 3):25–33
Baxter P (2003) Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochim Biophys Acta 1647:36–41
Bennett CL, Huynh HM, Chance PF, Glass IA, Gospe SM Jr (2005) Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures. Neurogenetics 6:143–149
Bok LA, Been JV, Struys EA, Jakobs C, Rijper EA, Willemsen MA (2010) Antenatal treatment in two Dutch families with pyridoxine-dependent seizures. Eur J Pediatr 169(3):297–303
Bok LA, Halbertsma FJ, Houterman S, Wevers RA, Vreeswijk C, Jakobs C, Struys EA, Van Der Hoeven JH, Sival DA, Willemsen MA (2012) Long-term outcome in pyridoxine-dependent epilepsy. Dev Med Child Neurol 54:849–854
Clayton PT (2006) B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis 29:317–326, Review
Clayton P, Plecko B (2008) Pyridoxine- and pyridoxalphosphate-dependent epilepsies. In: 40th European Metabolic Group meeting, Heidelberg. Milupa Metabolics GmbH, Friedrichsdorf, Germany. pp 31–40. ISBN 978-3-9811868-1-9
Farrant RD, Walker V, Mills G, Mellor JM, Langley GJ (2001) Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. J Biol Chem 276:15107–15116
Flynn MP, Martin MC, Moore PT, Stafford JA, Fleming GA, Phang JM (1989) Type II hyperprolinaemia in a pedigree of Irish travellers (nomads). Arch Dis Child 64:1699–1707
Footitt EJ, Heales SJ, Mills PB, Allen GF, Oppenheim M, Clayton PT (2011) Pyridoxal 5’-phosphate in cerebrospinal fluid; factors affecting concentration. J Inherit Metab Dis
Footitt EJ, Clayton PT, Mills K, Heales SJ, Neergheen V, Oppenheim M, Mills PB (2013) Measurement of plasma B(6) vitamer profiles in children with inborn errors of vitamin B6 metabolism using an LC-MS/MS method. J Inherit Metab Dis 36(1):139–145
Gallagher RC, Van Hove JL, Scharer G, Hyland K, Plecko B, Waters PJ, Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S, Salomons GS, Rosenberg EH, Struys EA, Jakobs C (2009) Folinic acid-responsive seizures are caused by α-amino adipic semialdehyde dehydrogenase deficiency and are genetically identical to pyridoxine-dependent epilepsy. Ann Neurol 65:550–556
Gospe S (2006) Pyridoxine dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment. Curr Opin Neurol 19:148–153
Hartmann H, Fingerhut M, Jakobs C, Plecko B (2011) Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity? Dev Med Child Neurol 53:1150–1153
Hoffmann GF, Schmitt B, Windfuhr M, Wagner N, Strehl H, Bagci S, Franz AR, Mills PB, Clayton PT, Baumgartner MR, Steinmann B, Bast T, Wolf NI, Zschocke J (2007) Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 30:96–99
Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, Heales SJ, Briddon A, Scheimberg I, Hoffmann GF, Zschocke J, Clayton PT (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 14:1077–1086
Mills PB, Struys EA, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MA, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT (2006) Mutations in the antiquitin (ALDH7A1) gene in patients with pyridoxine-dependent seizures. Nat Med 12:307–309
Mills PB, Footitt EJ, Mills KA, Tuschl K, Aylett S, Varadkar S, Hemingway C, Marlow N, Rennie J, Baxter P, Dulac O, Nabbout R, Craigen WJ, Schmitt B, Feillet F, Christensen E, De Lonlay P, Pike MG, Hughes MI, Struys EA, Jakobs C, Zuberi SM, Clayton PT (2010) Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 133:2148–2159
Plecko B, Stöckler S (2009) Vitamin B6 dependent seizures. Can J Neurol Sci 36(Suppl 2):73–77
Plecko B, Stöckler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C (2000) Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 48:121–125
Plecko B, Hikel C, Korenke GC, Schmitt B, Baumgartner M, Baumeister F, Jakobs C, Struys EA, Erwa W, Stöckler-Ipsiroglu S (2005) Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Neuropediatrics 36:200–205
Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys EA, Jakobs C, Hartmann H, Luecke T, di Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W (2007) Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy. Hum Mutat 28:19–26
Plecko B, Karl P, Mills Ph, Clayton P, Paschke E, Maier O, Hasselmann O, Schmiedl G, Kanz S, Connolly M, Wolf N, Struys E, Stockler S, Abela L, Hofer D (2013) Pyridoxine responsiveness in novel PNPO mutations. Neurology [in press]
Stockler S, Plecko B, Gospe SM, Coulter-Mackie M, Connolly M, van Karnebeek C, Mercimek-Mahmutoglu S, Hartmann H, Scharer G, Struys E, Tein I, Jakobs C, Clayton P, Van Hove JL (2011) Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 104(1–2):48–60
Struys EA, Bok LA, Emal D, Houterman S, Willemsen MA, Jakobs C (2012) The measurement of urinary Δ(1)-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in Antiquitin deficiency. J Inherit Metab Dis 5:909–916
van Karnebeek C, Hartmann H, Jaggumantri S, Bok L, Cheng B, Connolly M, Coughlin CR II, Das A, Gospe S Jr, Jakobs C, van der Lee JH, Mercimek-Mahmutoglu S, Meyer U, Struys E, Sinclair G, Van Hove J, Collet JP, Plecko BR, Stockler S (2012) Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials. Mol Genet Metab 107(3):335–344
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Plecko, B., Struys, E.A., Jakobs, C. (2014). Vitamin B6-Dependent and Responsive Disorders. In: Blau, N., Duran, M., Gibson, K., Dionisi Vici, C. (eds) Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40337-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-40337-8_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40336-1
Online ISBN: 978-3-642-40337-8
eBook Packages: MedicineMedicine (R0)